Vir Biotechnology opens new office in St. Louis - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 68%

Business News News

Business Business Latest News,Business Business Headlines

A San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis.

, Vir’s senior vice president of microbiology and virology and St. Louis site head, said the company’s new local office will focus on research and development, supporting pre-clinical testing to advance and commercialize its drug pipeline. Purcell said St. Louis' new office gives it proximity to research institutions and collaborators like Saint Louis University and Washington University and places it within a “thriving bioscience community.”Vir announced its St.

Scroll through the gallery above to take a look inside Vir's new office in the Cortex innovation district. Vir tapped HOK as architect for its new St. Louis office, with Tarlton Corp. acting as general contractor. Several local economic development groups said they were involved in securing Vir’s St. Louis expansion, including Greater St. Louis Inc., Missouri Partnership, Missouri Department of Economic Development, St. Louis Economic Development Partnership and St. Louis Development Corporation. As part of its expansion, Vir is eligible to receive state incentives though Missouri Works Program, which helps businesses access capital through withholdings or tax credits.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 78. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Vir Biotechnology opens new office in St. Louis - San Francisco Business TimesThe San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis, opening a new $41 million office within the Cortex innovation district. It says the new facility will be critical to advancing research to treat several infectious diseases, including Covid-19.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »

Vir Biotechnology opens new office in St. Louis - San Francisco Business TimesThe San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis, opening a new $41 million office within the Cortex innovation district. It says the new facility will be critical to advancing research to treat several infectious diseases, including Covid-19.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »